Haemonetics (HAE) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $119.79 --0%
Revenue Growth %: +5.6%
Financial Fact:
Net income: 0.39
Today's EPS Names:
TFS, PBNK, FNRN, More
Revenue Growth %: +5.6%
Financial Fact:
Net income: 0.39
Today's EPS Names:
TFS, PBNK, FNRN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $219.7 million versus the consensus estimate of $226.5 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TFS Financial (TFSL) Reports In-Line Q4 EPS
- Consensus Mining & Seigniorage Corporation (CMSG) Tops Q3 EPS by 331c
- Sanofi (SNY) Tops Q3 EPS by 199c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
